Evidence map›Paper›PMID 32947812›Full record

ArticleBrain sciences2020

Hyperhomocysteinemia and Endothelial Dysfunction in Multiple Sclerosis.

Ekaterina Dubchenko, Alexander Ivanov, Natalia Spirina, Nina Smirnova, Mikhail Melnikov, Alexey Boyko, Evgeniy Gusev, Aslan Kubatiev

Open access · goldAbstract read
In one paragraph

Article in Brain sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
2.8field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 28 citations in OpenAlex.

  1. Review
  2. Review
  3. Homocysteine Attack on Vascular Endothelium-Old and New Features.International journal of molecular sciences · 2025
    Review
  4. Article
  5. Article
  6. Review
  7. Controlling the Impact ofMedicina (Kaunas, Lithuania) · 2023
    Article
  8. Multiple Sclerosis: Inflammatory and Neuroglial Aspects.Current issues in molecular biology · 2023
    Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Ekaterina DubchenkoDepartment of Neuroimmunology of Federal Center of Brain and Neurotechnology of the Federal Medical-Biological Agency of Russia, 117997 Moscow, Russia.
Alexander IvanovFederal State Budgetary Scientific Institution "Institute of General Pathology and Pathophysiology", 125315 Moscow, Russia.
Natalia SpirinaDepartment of Nervous Diseases with Medical Genetics and Neurosurgery Yaroslavl State Medical University, 150000 Yaroslavl, Russia.
Nina SmirnovaDepartment of Neuroimmunology of Federal Center of Brain and Neurotechnology of the Federal Medical-Biological Agency of Russia, 117997 Moscow, Russia.
Mikhail MelnikovDepartment of Neuroimmunology of Federal Center of Brain and Neurotechnology of the Federal Medical-Biological Agency of Russia, 117997 Moscow, Russia.
Alexey BoykoDepartment of Neuroimmunology of Federal Center of Brain and Neurotechnology of the Federal Medical-Biological Agency of Russia, 117997 Moscow, Russia.
Evgeniy GusevDepartment of Neurology, Neurosurgery and Medical Genetic of Pirogov Russian National Research Medical University, 117997 Moscow, Russia.
Aslan KubatievFederal State Budgetary Scientific Institution "Institute of General Pathology and Pathophysiology", 125315 Moscow, Russia.
Pirogov Russian National Research Medical University · RUResearch Institute of General Pathology and Pathophysiology, the Russian Academy of Medical Sciences · RUFederal Medical-Biological Agency · RUYaroslavl State Medical Academy · RU

Funding

Ministry of health of the Russian Federation АААА-А19-119042590017-3
6 · The paper itself

Abstract

Endothelial dysfunction is recognized as one of the leading factors in the pathogenesis of diseases of the central nervous system of various etiologies. Numerous studies have shown the role of hyperhomocysteinemia in the development of endothelial dysfunction and the prothrombogenic state. The most important condition in the development of multiple sclerosis (MS) is a dysregulation of the blood-brain barrier (BBB) and transendothelial leukocyte migration. It has been proven that homocysteine also contributes to the damage of neurons by the mechanism of excitotoxicity and the induction of the apoptosis of neurons. These processes can be one of the factors of neurodegenerative brain damage, which plays a leading role in the progression of MS. This review describes the pleiotropic effect of homocysteine on these processes and its role in MS pathogenesis.

Indexed as

endothelial dysfunctionhomocysteinehyperhomocysteinemiamultiple sclerosis

Identifiers

PMID32947812
PMCPMC7564574
OpenAlexW3085750880

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.